Dr. Leontina-Elena Filipiuc is a Scientific Researcher III at the Advanced Center for Research and Development in Experimental Medicine “Prof. Ostin C. Mungiu” (CEMEX), “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania. She holds a Master’s degree in Pharmacy, completed residency training in Clinical Pharmacy, and earned a PhD in Medical Sciences (Medicine/Pharmacology) focused on natural and synthetic cannabinoids in chronic neuropathic pain. Her interdisciplinary background includes formal training in Computer Science and professional experience in software development and IT education, supporting her work at the interface of experimental pharmacology and data-driven research. With expertise in clinical pharmacy, experimental pharmacology, and preclinical research, her work connects mechanistic insights with translational applications in pain therapy and cannabinoid science. She contributes to in vivo and in vitro studies, pharmacokinetic modeling, and study design with rigorous ethical standards. She has participated in national, internal, private, and EU-supported projects and actively disseminates her research through publications and international conferences.

Bogdan-Ionel Tamba, MD, PhD, is a Professor in the Department of Pharmacology, Clinical Pharmacology and Algesiology, Head of the Advanced Center for Research and Development in Experimental Medicine “Prof. Ostin C. Mungiu” at “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania, and a Primary Physician in Clinical Pharmacology. His primary activity focuses on research leadership, project coordination, supervision of PhD and trainee students, and participation in numerous competitive research projects. He has authored over 100 publications in indexed journals, with an h-index of 29, reflecting sustained output in translational pharmacology. His training includes a habilitation degree, a PhD in Medicine, board certification in clinical pharmacology, and additional education in drug and medical device development and healthcare management. He is active in international professional societies and has received several awards for excellence in medical research. His research focuses on preclinical pharmacology and nociception, with expanded interests in nanotechnologies, drug-delivery systems, and cannabinoid pharmacology for neuropathic pain.

Maftuchah Rochmanti is the Director of Education at Universitas Airlangga and serves as the First Chair of the Executive Board of the Indonesian Pharmacology Association (Pengurus Besar Ikatan Farmakologi Indonesia – PB IKAFARI). She completed her doctoral and master’s degrees at the Faculty of Medicine, Universitas Airlangga. In her academic role, she teaches pharmacology at the Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine, Universitas Airlangga. Her research focuses on pharmacology in non-communicable diseases, particularly diabetes mellitus and dyslipidemia, encompassing both conventional pharmacotherapy and the development and evaluation of herbal medicines. She is also an established author of pharmacology textbooks for medical and nursing education, contributing significantly to the dissemination and standardization of pharmacological knowledge across health professions.

Igor Rubinić, MD, is a clinical pharmacologist at the Clinical Hospital Centre Rijeka and a doctoral student in biomedical sciences at the Faculty of Medicine, University of Rijeka, Croatia. His research focuses on antimicrobial stewardship, multidrug-resistant organisms, and microbiome-based interventions, including faecal microbiota transplantation. He is a member of EurFMT and serves on the Executive Board of the European Drug Utilization Research Group (EuroDURG).

Dr. Jack Feehan is a Vice Chancellor's Senior Research Fellow at RMIT University in the School of Health and Biomedical Sciences. He is an emerging leader focusing on chronic disease treatment, healthy aging, immunology, and regenerative medicine. His work includes investigating diabetes-associated dementia, immunomodulation, and the risks associated with high-dose vitamin supplementation.

Isis Souza is currently Assistant Professor at the Biomedical Sciences Institute at the Federal University of Rio de Janeiro (UFRJ). She has a degree cum laude in Biomedical Sciences (2015) and a Masters in Pharmacology and Medicinal Chemistry (2016), both from UFRJ. She holds a Ph.D. in Pharmaceutical Sciences (2020) from UFRJ with a short researh visit at the Universidad Pablo de Olavide, in Seville, Spain. She won the 23rd SBBq's Young Talent Award in Life Sciences, in 2019, and the CAPES' Theses Grand Prix in Life Sciences in 2021. She recently returned from a post-doctoral position at Université Paris-Saclay (France), supported by an EMBO Postdoctoral Fellowship. She has experience in neuropharmacology, neurovirology and drug development, mainly in behavioral assessment techniques in rodents and electrophysiological methods. She has a special interest in excitatory-inhibitory balance assessments in neurological disorders.